Log In
BCIQ
Print this Print this
 

Lactobacillus reuteri (IBP-9414)

  Manage Alerts
Collapse Summary General Information
Company Infant Bacterial Therapeutics AB
DescriptionFreeze-dried powder administered via a feeding tube or by mouth
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationColitis
Indication DetailsTreat necrotizing enterocolitis in neonates
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today